Anastomosis Devices Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029
Overview
Anastomosis Devices Market is expected to reach $4.26 Bn by 2029 from $ 2.45 Bn in 2022, at a CAGR of 8.2% during forecast period.
Anastomosis Devices Market Overview:
An anastomosis is a surgical connection between two tubular structures such as blood vessels, leaf veins, or streams. The two significant forms of anastomosis are vascular and gastrointestinal. The surgical anastomosis can be created using suture sewn by hand, mechanical staplers and biological glues, depending on the circumstances.
To know about the Research Methodology :- Request Free Sample Report
Anastomosis Devices Market Dynamics:
Rising surgical procedures along with growing incidence of cardiovascular and gastrointestinal diseases are the primary factors driving the market growth.
According to statistics, on average, more than 700,000 coronary artery bypass grafts (CABG) and 600,000 vascular procedures are performed every year globally. Rising incidences of myocardial infarction are expected to benefit the market growth. Anastomosis devices play a pivotal role in surgical procedures. As a result, increasing the prevalence of chronic diseases will surge demand for anastomosis devices that will expand industry growth. Anastomosis systems that are technologically advanced can minimize significant risks that arise during surgical procedures. The advantages of using these devices include less operating time, more convenience for surgeons, less anaesthesia exposure, and a lower risk of blood leakage contribute to the market growth. The presence of a supportive regulatory framework is contributing to the growth of the market. Rising reimbursement coverage for CABG procedures are projected to increase the adoption of anastomosis devices by surgeons. For instance, Medicare Part B covers coronary artery bypass graft surgery, coronary angioplasty, valve repair & replacement, and other comprehensive cardiac rehabilitation (CR) programs.
The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Anastomosis Devices Market Segment Analysis:
The Anastomosis Devices Market is segmented based on Product, Type and Application.
Based on the Product, the disposable segment held a dominant share in the year 2022. The segment is expected to witness positive growth during the forecast period, owing to the easily available array of disposable anastomosis products. Major Key players are involved in the production of disposable types of products. Disposable products reduce the risk of surgical site infections, cross-contamination, and other infections. They do not require reprocessing between consecutive uses thereby reducing reprocessing cost and speeding up the entire process.
Based on Application, the Cardiovascular Surgery segment is expected to grow at a faster pace during the forecast period. The increasing number of cardiac diseases demands technologically advanced products, propelling the growth of the segment. The segment dominance is due to the increased use of various instruments in various cardiac surgeries, such as surgical staplers, surgical sealants, and adhesives. The ability of these devices to decrease the risk of complications and eliminate anastomotic leakage has led to increased demand for them in aortic surgery, arrhythmia surgery, myectomy, and CABG procedures.
Anastomosis Devices Market Regional Insights:
North America dominated the Anastomosis Devices Market in 2022.
North America market is expected to dominate in the Anastomosis Devices Market with higher revenue share as compared to other regional markets, owing to increasing cardiovascular, ophthalmic, and other surgeries, favorable reimbursement policies, and the presence of prominent players operating in countries in this region. In August 2021, Dextera Surgical Inc. entered into a joint development program with Intuitive Surgical, Inc. for developing a novel surgical stapler for the latter’s da Vinci Surgical System. Also, an increasing number of hospitals, improvement in healthcare infrastructure, and increasing aging population contribute to the market growth in the region.
APAC is expected to be the fastest growing region during forecast period.
Major developing economies like Japan, China, and India are the main contributors to the APAC market. The regional market is estimated to experience the fastest growth during the forecast period, owing to improving economic conditions, growing healthcare awareness, and increasing the aging population in this region. Aged people are more susceptible to cardiovascular and gastrointestinal diseases, thereby presenting a huge target population for the industry.
The report also helps in understanding Anastomosis Devices Market dynamics, structure by analyzing the market segments and project the Anastomosis Devices Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Anastomosis Devices Market make the report investor’s guide.
Anastomosis Devices Market, Key developments:
• On January 18th, 2021, Intuitive Surgical has receivedFDA approval for its SureForm 45 Stapler.
• On March 19th, 2021, Baxter International Inc. acquired Mallinckrodt Pharmaceutical’s PREVELEAK Surgical Sealant and RECOTHROM Surgical Hemostat and Sealant Portfolio. This acquisition broadened Baxter’s portfolio of advanced surgical sealants.
Anastomosis Devices Market Scope: Inquire before buying
| Anastomosis Devices Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2018 to 2022 | Market Size in 2022: | US $ 2.45 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 8.2% | Market Size in 2029: | US $ 4.26 Bn. |
| Segments Covered: | by Product | Disposable Reusable |
|
| by Type | Surgical Staplers Surgical Sutures Surgical Sealants and Adhesives Others |
||
| by Application | Cardiovascular Surgery Gastrointestinal Surgery |
||
Anastomosis Devices Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Anastomosis Devices Market, Key Players:
1. Medtronic
2. LivaNova PLC
3. MAQUET Holding B.V. & Co. KG.
4. Dextera Surgical Inc.
5. Vitalitec Internaional Inc.
6. Synovis Micro Companies Alliance, Inc.
7. Ethicon US, LLC
8. Johnson & Johnson
9. B. Braun Melsungen AG
10. Smith & Nephew
11. EndoEvolution LLC
12. CryoLife, Inc.
13. Becton, Dickinson and Company
14. CONMED Corporation
15. Intuitive Surgical, Inc.
16. Boston Scientific Corporation
17. Baxter International, Inc.
18. Péters Surgical
19. Biosintex
20. Meril Life Sciences
Frequently Asked Questions:
1. Which region has the largest share in Anastomosis Devices Market?
Ans: North America region holds the highest share in 2022.
2. What is the growth rate of Anastomosis Devices Market?
Ans: The Anastomosis Devices Market is growing at a CAGR of 8.2% during forecasting period 2023-2029.
3. What segments are covered in Anastomosis Devices Market?
Ans: Anastomosis Devices Market is segmented into product, type, application and region.
4. Who are the key players in Anastomosis Devices Market?
Ans: The important key players in the Anastomosis Devices Market are – Medtronic, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Dextera Surgical Inc., Vitalitec Internaional Inc., Synovis Micro Companies Alliance, Inc., Ethicon US, LLC, Johnson & Johnson,
5. What is the study period of this market?
Ans: The Anastomosis Devices Market is studied from 2022 to 2029.